GMEB2 (glucocorticoid modulatory element binding protein 2) is a trans-acting transcription factor that binds to glucocorticoid modulatory elements (GMEs) in gene promoters, enhancing sensitivity to glucocorticoid receptor signaling 1. GMEB2 functions as part of a protein complex that modulates glucocorticoid-mediated gene expression, including effects on T cell apoptosis 2. The protein exhibits DNA-binding activity and localizes to the nucleus and nucleoplasm, where it regulates RNA polymerase II-dependent transcription [GO annotations]. GMEB2 also possesses auxiliary roles in parvovirus replication. Clinically, GMEB2 has emerged as a significant biomarker in multiple disease contexts. Variants in the GMEB2 region on chromosome 20.33 show genome-wide significant associations with glioma risk, particularly in IDH wild-type gliomas 3, and this association demonstrates sex-specific effects 4. A functional SNP (rs3761124) in an enhancer region modulates GMEB2 expression alongside other nearby genes in glioblastoma 5. Additionally, circulating GMEB2 transcript levels show differential expression during labor induction and serve as a predictive biomarker for successful vaginal delivery 6. GMEB2 has also been identified as a differentially expressed gene in prostate cancer 7, suggesting broader roles in disease pathology. The localized availability of GMEB2 at temporo-limbic brain network hubs suggests potential involvement in stress-related neurobiological pathways 8.